Erratum to: Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study.
Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, 227-8501, Japan. koiwa-f@med.showa-u.ac.jp.
Fumihiko
F
Koiwa
Biostatistics, Faculty of Pharmaceutical Sciences, Josai University, Sakado, Japan.
Akira
A
Terao